Diebold, Inc. (DBD) Tops Q3 EPS by 9c; Boosts FY11 EPS Outlook
Tweet
Share
E-mailGet Alerts DBD Hot Sheet
Join SI Premium – FREE
Diebold, Inc. (NYSE: DBD) reported Q3 EPS of $0.69, $0.09 better than the analyst estimate of $0.60. Revenue for the quarter came in at $709.3 million versus the consensus estimate of $762.95 million.
Diebold, Inc. sees FY2011 EPS of $2.15-$2.25, versus prior guidance of $2.00-$2.20 and the consensus of $2.09.
Diebold, Inc. sees FY2011 EPS of $2.15-$2.25, versus prior guidance of $2.00-$2.20 and the consensus of $2.09.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Phibro Animal Health (PAHC) Tops Q4 EPS by 13c; Offers Guidance
- Donaldson (DCI) Tops Q4 EPS by 2c ; Offers Guidance
- Nutanix (NTNX) Tops Q4 EPS by 11c, Beats in Revenue; Offers Q1 Revenue Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
